Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada; Department of Medicine, Université de Montréal, Montréal, Canada
Céline M Laumont
Deeley Research Centre, BC Cancer, Victoria, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, Canada
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada; Department of Computer Science and Operations Research, Université de Montréal, Montréal, Canada; Fred Hutchinson Cancer Center, Seattle, United States; Department of Physics, University of Washington, Seattle, United States
Krystel Vincent
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
Leslie Hesnard
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
Sylvie Brochu
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
Caroline Côté
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
Juliette F Humeau
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
Éric Bonneil
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
Joel Lanoix
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
Chantal Durette
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
Patrick Gendron
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
Ellen R Richie
Department of Epigenetics and Molecular Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Houston, United States
Sébastien Lemieux
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, Canada
Pierre Thibault
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada; Department of Chemistry, Université de Montréal, Montréal, Canada
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada; Department of Medicine, Université de Montréal, Montréal, Canada
Transposable elements (TEs) are repetitive sequences representing ~45% of the human and mouse genomes and are highly expressed by medullary thymic epithelial cells (mTECs). In this study, we investigated the role of TEs on T-cell development in the thymus. We performed multiomic analyses of TEs in human and mouse thymic cells to elucidate their role in T-cell development. We report that TE expression in the human thymus is high and shows extensive age- and cell lineage-related variations. TE expression correlates with multiple transcription factors in all cell types of the human thymus. Two cell types express particularly broad TE repertoires: mTECs and plasmacytoid dendritic cells (pDCs). In mTECs, transcriptomic data suggest that TEs interact with transcription factors essential for mTEC development and function (e.g., PAX1 and REL), and immunopeptidomic data showed that TEs generate MHC-I-associated peptides implicated in thymocyte education. Notably, AIRE, FEZF2, and CHD4 regulate small yet non-redundant sets of TEs in murine mTECs. Human thymic pDCs homogenously express large numbers of TEs that likely form dsRNA, which can activate innate immune receptors, potentially explaining why thymic pDCs constitutively secrete IFN ɑ/β. This study highlights the diversity of interactions between TEs and the adaptive immune system. TEs are genetic parasites, and the two thymic cell types most affected by TEs (mTEcs and pDCs) are essential to establishing central T-cell tolerance. Therefore, we propose that orchestrating TE expression in thymic cells is critical to prevent autoimmunity in vertebrates.